• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血吸虫病引起的肺动脉高压的人口统计学和临床特征与其他病因无法区分。

Demographic and clinical characteristics of pulmonary arterial hypertension caused by schistosomiasis are indistinguishable from other etiologies.

机构信息

Universidade de Pernambuco, Departamento de Hipertensão Pulmonar, Pronto-Socorro Cardiológico de Pernambuco, Recife, PE, Brasil.

Universidade de Pernambuco, Departamento de Ecocardiografia, Recife, PE, Brasil.

出版信息

Rev Soc Bras Med Trop. 2020 Feb 7;53:e20190418. doi: 10.1590/0037-8682-0418-2019. eCollection 2020.

DOI:10.1590/0037-8682-0418-2019
PMID:32049203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7083352/
Abstract

INTRODUCTION

Pulmonary arterial hypertension (PAH) is a serious pulmonary circulation disease caused by several etiologies, including schistosomiasis. The present study retrospectively evaluated the clinical and hemodynamic characteristics of patients with schistosomal PAH (PAH-Sch) compared to those of non-Sch PAH patients (non-Sch PAH).

METHODS

Patients treated at the Pronto-Socorro Cardiológico de Pernambuco and diagnosed by right cardiac catheterization were divided into PAH-Sch and non-Sch PAH groups. Their socio-demographic and clinical characteristics, N-terminal-pro B-type natriuretic peptide (NT-proBNP), and echocardiography and hemodynamic parameters were retrospectively reviewed.

RESULTS

Among the included 98 patients (mean age, 45 ± 14 years; 68 women [69.4%]), we found 56 PAH-Sch and 42 non-Sch PAH. The age distribution was heterogeneous in the PAH-Sch group, with patients predominantly ranging from 50-59 (p <0.004). Dyspnea was the most common symptom, reported by 92 patients (93.8%), and commonly present for over two years prior to diagnosis. Clinical symptoms were similar in both groups, with no differences in functional class, pulmonary artery systolic pressure (p = 0.102), 6-minute walk test score (p = 0.234), NT-proBNP serum levels (p = 0.081), or hemodynamic parameters.

CONCLUSIONS

Patients with PAH-Sch present clinical, laboratory, and hemodynamic profiles similar to those with PAH resulting from other etiologies of poor prognosis. PAH is an important manifestation of schistosomiasis in endemic regions that is often diagnosed late.

摘要

简介

肺动脉高压(PAH)是一种由多种病因引起的严重肺循环疾病,包括血吸虫病。本研究回顾性评估了血吸虫性 PAH(PAH-Sch)患者与非-Sch PAH 患者的临床和血流动力学特征。

方法

在 Pronto-Socorro Cardiológico de Pernambuco 接受治疗并通过右心导管诊断的患者被分为 PAH-Sch 和非-Sch PAH 组。回顾性分析了他们的社会人口统计学和临床特征、N 端脑利钠肽前体(NT-proBNP)以及超声心动图和血流动力学参数。

结果

在纳入的 98 名患者(平均年龄 45±14 岁;68 名女性[69.4%])中,我们发现 56 名 PAH-Sch 和 42 名非-Sch PAH。PAH-Sch 组的年龄分布不均匀,患者主要分布在 50-59 岁(p<0.004)。呼吸困难是最常见的症状,92 名患者(93.8%)有此症状,且在诊断前通常已存在两年以上。两组的临床症状相似,在功能分级、肺动脉收缩压(p=0.102)、6 分钟步行试验评分(p=0.234)、NT-proBNP 血清水平(p=0.081)或血流动力学参数方面均无差异。

结论

PAH-Sch 患者的临床表现、实验室和血流动力学特征与其他病因导致的预后不良的 PAH 相似。在流行地区,PAH 是血吸虫病的一个重要表现,往往诊断较晚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e66/7083352/e997c660853d/1678-9849-rsbmt-53-e20190418-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e66/7083352/e997c660853d/1678-9849-rsbmt-53-e20190418-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e66/7083352/e997c660853d/1678-9849-rsbmt-53-e20190418-gf1.jpg

相似文献

1
Demographic and clinical characteristics of pulmonary arterial hypertension caused by schistosomiasis are indistinguishable from other etiologies.血吸虫病引起的肺动脉高压的人口统计学和临床特征与其他病因无法区分。
Rev Soc Bras Med Trop. 2020 Feb 7;53:e20190418. doi: 10.1590/0037-8682-0418-2019. eCollection 2020.
2
Schistosomiasis-associated pulmonary arterial hypertension: a systematic review.血吸虫病相关肺动脉高压:系统评价。
Eur Respir Rev. 2020 Feb 5;29(155). doi: 10.1183/16000617.0089-2019. Print 2020 Mar 31.
3
Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension.血吸虫病相关性肺动脉高压中的肺动脉扩大
BMC Pulm Med. 2015 Oct 12;15:118. doi: 10.1186/s12890-015-0115-y.
4
Contrasting cardiopulmonary responses to incremental exercise in patients with schistosomiasis-associated and idiopathic pulmonary arterial hypertension with similar resting hemodynamic impairment.对比伴有相似静息血流动力学障碍的血吸虫病相关和特发性肺动脉高压患者递增运动的心肺反应。
PLoS One. 2014 Feb 3;9(2):e87699. doi: 10.1371/journal.pone.0087699. eCollection 2014.
5
The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension.靶向治疗在血吸虫病相关肺动脉高压中的作用。
Chest. 2012 Apr;141(4):923-928. doi: 10.1378/chest.11-0483. Epub 2011 Oct 26.
6
TGF beta and IL13 in Schistosomiasis mansoni associated pulmonary arterial hypertension; a descriptive study with comparative groups.曼氏血吸虫病相关肺动脉高压中 TGF-β 和 IL13;一项具有对照组的描述性研究。
BMC Infect Dis. 2014 May 21;14:282. doi: 10.1186/1471-2334-14-282.
7
Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients.心房利钠肽可预测系统性硬化症患者的疾病进展和发生手指溃疡。
J Cardiovasc Med (Hagerstown). 2019 Nov;20(11):771-779. doi: 10.2459/JCM.0000000000000852.
8
Schistosomiasis-associated pulmonary arterial hypertension: survival in endemic area in Brazil.血吸虫病相关性肺动脉高压:巴西流行地区的生存情况
Int J Cardiol Heart Vasc. 2019 Oct 31;25:100373. doi: 10.1016/j.ijcha.2019.100373. eCollection 2019 Dec.
9
Survival in schistosomiasis-associated pulmonary arterial hypertension.血吸虫病相关肺动脉高压的生存情况。
J Am Coll Cardiol. 2010 Aug 24;56(9):715-20. doi: 10.1016/j.jacc.2010.03.065.
10
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.血清N末端脑钠肽作为肺动脉高压患者的预后参数。
Chest. 2006 May;129(5):1313-21. doi: 10.1378/chest.129.5.1313.

引用本文的文献

1
Rare but serious: pulmonary vascular disease around the world.罕见但严重:全球范围内的肺血管疾病
JHLT Open. 2025 Jul 18;9:100327. doi: 10.1016/j.jhlto.2025.100327. eCollection 2025 Aug.
2
Global Landscape of Infection-Induced Pulmonary Hypertension.感染性肺动脉高压的全球概况
Infect Dis Rep. 2025 Apr 17;17(2):35. doi: 10.3390/idr17020035.
3
Clinical, Functional, and Hemodynamic Profile of Schistosomiasis-Associated Pulmonary Arterial Hypertension Patients in Brazil: Systematic Review and Meta-Analysis.巴西血吸虫病相关性肺动脉高压患者的临床、功能和血流动力学特征:系统评价与荟萃分析

本文引用的文献

1
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina.左主干冠状动脉受压在肺动脉高压和心绞痛患者。
J Am Coll Cardiol. 2017 Jun 13;69(23):2808-2817. doi: 10.1016/j.jacc.2017.03.597.
2
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015 ESC/ERS 肺动脉高压诊断与治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断与治疗工作组制定:该指南得到了欧洲儿科和先天性心脏病协会(AEPC)以及国际心肺移植学会(ISHLT)的认可。
Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29.
3
Infect Dis Rep. 2025 Mar 4;17(2):22. doi: 10.3390/idr17020022.
4
Schistosome-Associated Pulmonary Arterial Hypertension: A Review Emphasizing Pathogenesis.血吸虫相关性肺动脉高压:一篇着重于发病机制的综述
Front Cardiovasc Med. 2021 Oct 5;8:724254. doi: 10.3389/fcvm.2021.724254. eCollection 2021.
5
Prevalence of -associated Pulmonary Hypertension in China: An Echocardiography-based Assessment.中国 - 相关肺动脉高压的患病率:基于超声心动图的评估。 (注:原文中“-associated”处应该有具体疾病名称缺失)
Ann Am Thorac Soc. 2021 Dec;18(12):2095-2098. doi: 10.1513/AnnalsATS.202012-1573RL.
6
Sex Dimorphism in Pulmonary Hypertension: The Role of the Sex Chromosomes.肺动脉高压中的性别二态性:性染色体的作用。
Antioxidants (Basel). 2021 May 14;10(5):779. doi: 10.3390/antiox10050779.
7
Schistosomiasis Pulmonary Arterial Hypertension.血吸虫病性肺动脉高压。
Front Immunol. 2020 Dec 10;11:608883. doi: 10.3389/fimmu.2020.608883. eCollection 2020.
Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases.南半球的肺动脉高压:巴西新发病例登记研究结果
Chest. 2015 Feb;147(2):495-501. doi: 10.1378/chest.14-1036.
4
Updated clinical classification of pulmonary hypertension.肺动脉高压的最新临床分类。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41. doi: 10.1016/j.jacc.2013.10.029.
5
The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension.靶向治疗在血吸虫病相关肺动脉高压中的作用。
Chest. 2012 Apr;141(4):923-928. doi: 10.1378/chest.11-0483. Epub 2011 Oct 26.
6
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).预测肺动脉高压患者的生存情况:来自评估早期和长期肺动脉高压疾病管理登记研究(REVEAL)的见解。
Circulation. 2010 Jul 13;122(2):164-72. doi: 10.1161/CIRCULATIONAHA.109.898122. Epub 2010 Jun 28.
7
[Pulmonary hypertension associated with acquired immunodeficiency syndrome: presentation of five cases and review of the literature].
Rev Soc Bras Med Trop. 2009 Jul-Aug;42(4):452-7. doi: 10.1590/s0037-86822009000400018.
8
Diagnosis and assessment of pulmonary arterial hypertension.肺动脉高压的诊断与评估
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S55-S66. doi: 10.1016/j.jacc.2009.04.011.
9
Cardiopulmonary manifestations of hepatosplenic schistosomiasis.肝脾型血吸虫病的心肺表现
Circulation. 2009 Mar 24;119(11):1518-23. doi: 10.1161/CIRCULATIONAHA.108.803221. Epub 2009 Mar 9.
10
Prevalence of pulmonary hypertension in patients with schistosomal liver fibrosis.
Ann Trop Med Parasitol. 2009 Mar;103(2):129-43. doi: 10.1179/136485909X398168.